JP2013525820A - 関節リウマチの発症に関するリスクを診断し、病期分類し、予測し、治療レスポンダーを同定するための方法 - Google Patents
関節リウマチの発症に関するリスクを診断し、病期分類し、予測し、治療レスポンダーを同定するための方法 Download PDFInfo
- Publication number
- JP2013525820A JP2013525820A JP2013509303A JP2013509303A JP2013525820A JP 2013525820 A JP2013525820 A JP 2013525820A JP 2013509303 A JP2013509303 A JP 2013509303A JP 2013509303 A JP2013509303 A JP 2013509303A JP 2013525820 A JP2013525820 A JP 2013525820A
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- less
- healthy volunteers
- subject
- totmmp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 284
- 206010039073 rheumatoid arthritis Diseases 0.000 title abstract description 218
- 208000027866 inflammatory disease Diseases 0.000 claims abstract description 296
- 102000013691 Interleukin-17 Human genes 0.000 claims description 1018
- 108050003558 Interleukin-17 Proteins 0.000 claims description 1018
- 108090001005 Interleukin-6 Proteins 0.000 claims description 315
- 239000000523 sample Substances 0.000 claims description 190
- 238000002560 therapeutic procedure Methods 0.000 claims description 93
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims description 91
- 102000003777 Interleukin-1 beta Human genes 0.000 claims description 86
- 108090000193 Interleukin-1 beta Proteins 0.000 claims description 86
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 20
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 15
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 13
- 208000011231 Crohn disease Diseases 0.000 claims description 13
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 13
- 201000010099 disease Diseases 0.000 claims description 13
- 201000004681 Psoriasis Diseases 0.000 claims description 12
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 11
- 230000002757 inflammatory effect Effects 0.000 claims description 8
- 208000035475 disorder Diseases 0.000 claims description 7
- 208000012201 sexual and gender identity disease Diseases 0.000 claims description 6
- 208000015891 sexual disease Diseases 0.000 claims description 6
- 241000282414 Homo sapiens Species 0.000 claims description 5
- 239000013610 patient sample Substances 0.000 claims description 5
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 claims 18
- 101100537532 Rattus norvegicus Tnni3 gene Proteins 0.000 claims 9
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 102000004889 Interleukin-6 Human genes 0.000 description 201
- 229940100601 interleukin-6 Drugs 0.000 description 201
- 102100036859 Troponin I, cardiac muscle Human genes 0.000 description 108
- 101710128251 Troponin I, cardiac muscle Proteins 0.000 description 108
- 239000000090 biomarker Substances 0.000 description 50
- 229940079593 drug Drugs 0.000 description 19
- 239000003814 drug Substances 0.000 description 19
- 210000002966 serum Anatomy 0.000 description 13
- 210000002381 plasma Anatomy 0.000 description 7
- 102000004127 Cytokines Human genes 0.000 description 6
- 108090000695 Cytokines Proteins 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 238000003018 immunoassay Methods 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 5
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241001303910 Erenna Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 description 2
- 102000000589 Interleukin-1 Human genes 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- 241000406668 Loxodonta cyclotis Species 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- 206010028289 Muscle atrophy Diseases 0.000 description 2
- 208000032234 No therapeutic response Diseases 0.000 description 2
- 241000283080 Proboscidea <mammal> Species 0.000 description 2
- 201000001880 Sexual dysfunction Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010051083 Therapy responder Diseases 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- -1 and optionally Proteins 0.000 description 2
- 239000012131 assay buffer Substances 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000003176 fibrotic effect Effects 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- 239000000833 heterodimer Substances 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000020763 muscle atrophy Effects 0.000 description 2
- 201000000585 muscular atrophy Diseases 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 231100000872 sexual dysfunction Toxicity 0.000 description 2
- 210000001179 synovial fluid Anatomy 0.000 description 2
- 201000004595 synovitis Diseases 0.000 description 2
- 239000003656 tris buffered saline Substances 0.000 description 2
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000004388 Interleukin-4 Human genes 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 229940028885 interleukin-4 Drugs 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008409 synovial inflammation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/34—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Corynebacterium (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
- G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
- G01N2800/205—Scaling palpular diseases, e.g. psoriasis, pytiriasis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33208110P | 2010-05-06 | 2010-05-06 | |
| US61/332,081 | 2010-05-06 | ||
| US201061428500P | 2010-12-30 | 2010-12-30 | |
| US61/428,500 | 2010-12-30 | ||
| US201161444702P | 2011-02-19 | 2011-02-19 | |
| US61/444,702 | 2011-02-19 | ||
| PCT/US2011/035584 WO2011140484A1 (en) | 2010-05-06 | 2011-05-06 | Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013525820A true JP2013525820A (ja) | 2013-06-20 |
| JP2013525820A5 JP2013525820A5 (enExample) | 2014-07-24 |
Family
ID=44904110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013509303A Pending JP2013525820A (ja) | 2010-05-06 | 2011-05-06 | 関節リウマチの発症に関するリスクを診断し、病期分類し、予測し、治療レスポンダーを同定するための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20110301053A1 (enExample) |
| EP (1) | EP2566971B1 (enExample) |
| JP (1) | JP2013525820A (enExample) |
| AU (1) | AU2011249908A1 (enExample) |
| CA (1) | CA2798149A1 (enExample) |
| WO (1) | WO2011140484A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130261016A1 (en) * | 2012-03-28 | 2013-10-03 | Meso Scale Technologies, Llc | Diagnostic methods for inflammatory disorders |
| AU2014407088B2 (en) | 2014-09-26 | 2021-09-23 | Somalogic Operating Co., Inc. | Cardiovascular risk event prediction and uses thereof |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030125231A1 (en) * | 2001-05-23 | 2003-07-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents useful in the treatment of inflammatory disease |
| JP2007506100A (ja) * | 2003-09-15 | 2007-03-15 | オクラホマ メディカル リサーチ ファウンデーション | 炎症性疾患および自己免疫疾患を診断、治療および評価するためにサイトカインアッセイを用いる方法 |
| JP2008500803A (ja) * | 2003-07-08 | 2008-01-17 | ジェネンテック・インコーポレーテッド | Ｉｌ−１７異種ポリペプチドとその治療上の用途 |
| JP2008532936A (ja) * | 2005-02-14 | 2008-08-21 | ワイス | インターロイキン−１７ｆ抗体及び他のｉｌ−１７ｆシグナル伝達拮抗物質並びにそれらの使用 |
| WO2008121865A1 (en) * | 2007-03-28 | 2008-10-09 | Wyeth | Methods and compositions for modulating il-17f/il-17a biological activity |
| US20090155271A1 (en) * | 2005-09-28 | 2009-06-18 | Zymogenetics, Inc. | Il-17a and il-17f antagonists and methods of using the same |
| WO2009126380A2 (en) * | 2008-03-05 | 2009-10-15 | Singulex, Inc. | Methods and compositions for highly sensitive detection of molecules |
| US20090317400A1 (en) * | 2008-05-05 | 2009-12-24 | Krzysztof Masternak | Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof |
| JP2010071833A (ja) * | 2008-09-19 | 2010-04-02 | Kyoto Univ | 関節リウマチ疾患の検査方法および検査用キット |
| JP2010511056A (ja) * | 2006-11-29 | 2010-04-08 | ジェネンテック インコーポレイテッド | Ｉｌ−１７ａ／ｆヘテロ二量体ポリペプチドおよびその治療上の使用 |
Family Cites Families (133)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4071298A (en) | 1974-06-27 | 1978-01-31 | Stanford Research Institute | Laser Raman/fluorescent device for analyzing airborne particles |
| DE2732272C2 (de) | 1977-07-16 | 1979-07-05 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts, 6900 Heidelberg | Verfahren und Vorrichtung zur Fluoreszenzanalyse von gefärbten Partikeln, insbesondere biologischen Zellen |
| US4251733A (en) | 1978-06-29 | 1981-02-17 | Hirleman Jr Edwin D | Technique for simultaneous particle size and velocity measurement |
| US4172227A (en) | 1978-07-21 | 1979-10-23 | Becton, Dickinson And Company | Flow microfluorometer |
| US4452773A (en) | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
| US4521733A (en) | 1983-05-23 | 1985-06-04 | General Electric Company | NMR Imaging of the transverse relaxation time using multiple spin echo sequences |
| US4768879A (en) | 1986-06-17 | 1988-09-06 | The Dow Chemical Company | Method for measuring the size of objects in a fluid medium |
| US4770183A (en) | 1986-07-03 | 1988-09-13 | Advanced Magnetics Incorporated | Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents |
| US4988191A (en) | 1987-03-09 | 1991-01-29 | University Of Illinois | Electro-optical method and system for determining the direction of motion in double-exposure velocimetry by shifting an optical image field |
| US5041733A (en) | 1987-03-20 | 1991-08-20 | Agency Of Industrial Science & Technology | Method and apparatus for identifying chromosomes or cells |
| DE3720844A1 (de) | 1987-06-24 | 1989-01-05 | Stefan Miltenyi | Trennsaeule fuer die magnetische separierung von zellen, zellaggregaten, und zellulaeren bestandteilen |
| US4793705A (en) | 1987-10-07 | 1988-12-27 | The United States Of America As Represented By The United States Department Of Energy | Single molecule tracking |
| US4927265A (en) | 1988-04-29 | 1990-05-22 | 501 Microphoretic Systems, Inc. | Detector for fluorescence and absorption spectroscopy |
| US5155581A (en) | 1988-05-06 | 1992-10-13 | Minolta Camera Kabushiki Kaisha | Electronic still video camera |
| US5002389A (en) | 1988-12-22 | 1991-03-26 | Honeywell Inc. | Pulsed fluorescence velocimeter |
| US5385707A (en) | 1988-12-28 | 1995-01-31 | Stefan Miltenyi | Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same |
| US4979824A (en) | 1989-05-26 | 1990-12-25 | Board Of Trustees Of The Leland Stanford Junior University | High sensitivity fluorescent single particle and single molecule detection apparatus and method |
| US5108179A (en) | 1989-08-09 | 1992-04-28 | Myers Stephen A | System and method for determining changes in fluorescence of stained nucleic acid in electrophoretically separated bands |
| US5274240A (en) | 1990-01-12 | 1993-12-28 | The Regents Of The University Of California | Capillary array confocal fluorescence scanner and method |
| US5770029A (en) | 1996-07-30 | 1998-06-23 | Soane Biosciences | Integrated electrophoretic microdevices |
| CA2079005A1 (en) | 1990-04-11 | 1991-10-12 | Geoffrey Stephen Begg | Methods and apparatus allowing sequential chemical reactions |
| US5094594A (en) | 1990-04-23 | 1992-03-10 | Genomyx, Incorporated | Piezoelectric pumping device |
| US5230997A (en) | 1990-07-19 | 1993-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of detecting the presence of human herpesvirus-7 infection |
| US5269937A (en) | 1990-10-23 | 1993-12-14 | Cetus Corporation | HPLC light scattering detector for biopolymers |
| US5605662A (en) | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
| US5846708A (en) | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
| US5290834A (en) | 1991-12-04 | 1994-03-01 | Rohm & Haas Company | Method for controlling elution rate of agent |
| US5209834A (en) | 1992-03-09 | 1993-05-11 | The United States Of America As Represented By The United States Department Of Energy | Ordered transport and identification of particles |
| DK0679251T3 (da) | 1993-01-18 | 1999-01-25 | Evotec Biosystems Aktiengesell | Fremgangsmåde og apparat til vurdering af biopolymerers fitness |
| GB9301122D0 (en) | 1993-01-21 | 1993-03-10 | Scient Generics Ltd | Method of analysis/separation |
| US5547849A (en) | 1993-02-17 | 1996-08-20 | Biometric Imaging, Inc. | Apparatus and method for volumetric capillary cytometry |
| JPH06265447A (ja) | 1993-03-16 | 1994-09-22 | Hitachi Ltd | 微量反応装置およびこれを使用する微量成分測定装置 |
| US5543838A (en) | 1993-08-31 | 1996-08-06 | Xerox Corporation | Signal multiplexing system for an image sensor array |
| JP3290786B2 (ja) | 1993-11-26 | 2002-06-10 | シスメックス株式会社 | 粒子分析装置 |
| DE4405005A1 (de) | 1994-02-17 | 1995-08-24 | Rossendorf Forschzent | Mikro-Fluiddiode |
| US5540494A (en) | 1994-06-03 | 1996-07-30 | Purvis, Jr.; Norman B. | Method and apparatus for determining absolute particle size, surface area and volume normalized fluorescence using forward angle light scatter intensity in flow cytometry |
| US6001229A (en) | 1994-08-01 | 1999-12-14 | Lockheed Martin Energy Systems, Inc. | Apparatus and method for performing microfluidic manipulations for chemical analysis |
| US5658413A (en) | 1994-10-19 | 1997-08-19 | Hewlett-Packard Company | Miniaturized planar columns in novel support media for liquid phase analysis |
| US5645702A (en) | 1995-06-07 | 1997-07-08 | Hewlett-Packard Company | Low voltage miniaturized column analytical apparatus and method |
| US5571410A (en) | 1994-10-19 | 1996-11-05 | Hewlett Packard Company | Fully integrated miniaturized planar liquid sample handling and analysis device |
| US5603351A (en) | 1995-06-07 | 1997-02-18 | David Sarnoff Research Center, Inc. | Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device |
| US5585069A (en) | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
| FI98765C (fi) | 1995-01-16 | 1997-08-11 | Erkki Soini | Virtaussytometrinen menetelmä ja laite |
| DE19508366C2 (de) | 1995-03-10 | 1998-01-29 | Evotec Biosystems Gmbh | Verfahren zum direkten Nachweisen weniger Nucleinsäurestränge |
| US5793485A (en) | 1995-03-20 | 1998-08-11 | Sandia Corporation | Resonant-cavity apparatus for cytometry or particle analysis |
| US5682038A (en) | 1995-04-06 | 1997-10-28 | Becton Dickinson And Company | Fluorescent-particle analyzer with timing alignment for analog pulse subtraction of fluorescent pulses arising from different excitation locations |
| US6991907B1 (en) | 1995-04-18 | 2006-01-31 | Biosite, Inc. | Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays |
| DE19524572A1 (de) | 1995-07-06 | 1997-01-09 | Bayer Ag | Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Immunoassays, bestehend aus den Analyten oder Teilsequenzen davon, die an inerten Trägermoleküle konjugiert sind |
| US5798222A (en) | 1995-07-17 | 1998-08-25 | Guava Technologies, Inc. | Apparatus for monitoring substances in organisms |
| US6132580A (en) | 1995-09-28 | 2000-10-17 | The Regents Of The University Of California | Miniature reaction chamber and devices incorporating same |
| US5716825A (en) | 1995-11-01 | 1998-02-10 | Hewlett Packard Company | Integrated nucleic acid analysis system for MALDI-TOF MS |
| DE19548028A1 (de) | 1995-12-21 | 1997-06-26 | Bayer Ag | Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Sandwich-Immunoassays, bestehend aus einem Antikörper gegen einen der im Assay benutzten Antikörper und einer Sequenz des Analyten |
| US5746901A (en) | 1996-04-05 | 1998-05-05 | Regents Of The University Of California | Hybrid slab-microchannel gel electrophoresis system |
| US6399023B1 (en) | 1996-04-16 | 2002-06-04 | Caliper Technologies Corp. | Analytical system and method |
| US5795758A (en) | 1997-04-18 | 1998-08-18 | Smithkline Beecham Corporation | DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae |
| US5863801A (en) | 1996-06-14 | 1999-01-26 | Sarnoff Corporation | Automated nucleic acid isolation |
| DE19630956A1 (de) | 1996-07-31 | 1998-02-05 | Basf Ag | Verfahren und Vorrichtung zur Raman-Korrelationsspektroskopie |
| DE19634873A1 (de) | 1996-08-29 | 1998-03-12 | Boehringer Mannheim Gmbh | System zur Unterscheidung fluoreszierender Molekülgruppen durch zeitaufgelöste Fluoreszenzmessung |
| DE19647927A1 (de) | 1996-11-20 | 1998-05-28 | Bayer Ag | Verfahren zur Herstellung einer stabilen Troponin I Präparation und dessen Verwendung als Kalibrator in Immunoassays |
| DE19649048C1 (de) | 1996-11-27 | 1998-04-09 | Evotec Biosystems Gmbh | Verfahren zur Unterscheidung oder Erfassung von Partikeln in einer Probe durch Identifizierung von Signalabschnitten zeitaufgelöster, optischer Rohsignale aus der Probe auf Basis von Einzelphotonendetektion |
| US5795158A (en) | 1996-12-02 | 1998-08-18 | Warinner; Peter | Apparatus to review clinical microbiology |
| ATE273381T1 (de) | 1997-02-12 | 2004-08-15 | Eugene Y Chan | Verfahren zur analyse von polymeren |
| US5999250A (en) | 1997-03-17 | 1999-12-07 | Tsi Corporation | System for detecting fluorescing components in aerosols |
| US6235471B1 (en) | 1997-04-04 | 2001-05-22 | Caliper Technologies Corp. | Closed-loop biochemical analyzers |
| US5985214A (en) | 1997-05-16 | 1999-11-16 | Aurora Biosciences Corporation | Systems and methods for rapidly identifying useful chemicals in liquid samples |
| US6710871B1 (en) | 1997-06-09 | 2004-03-23 | Guava Technologies, Inc. | Method and apparatus for detecting microparticles in fluid samples |
| GB2326229A (en) | 1997-06-13 | 1998-12-16 | Robert Jeffrey Geddes Carr | Detecting and analysing submicron particles |
| US5989402A (en) | 1997-08-29 | 1999-11-23 | Caliper Technologies Corp. | Controller/detector interfaces for microfluidic systems |
| US6130101A (en) | 1997-09-23 | 2000-10-10 | Molecular Probes, Inc. | Sulfonated xanthene derivatives |
| US6143152A (en) | 1997-11-07 | 2000-11-07 | The Regents Of The University Of California | Microfabricated capillary array electrophoresis device and method |
| US6049380A (en) | 1997-11-12 | 2000-04-11 | Regents Of The University Of California | Single molecule identification using selected fluorescence characteristics |
| WO1999026067A1 (en) | 1997-11-18 | 1999-05-27 | Bio-Rad Laboratories, Inc. | Multiplex flow immunoassays with magnetic particles as solid phase |
| US6041515A (en) | 1998-01-12 | 2000-03-28 | Life Technologies, Inc. | Apparatus for drying solutions containing macromolecules |
| SE9800360D0 (sv) | 1998-02-06 | 1998-02-06 | Goeteborg University Science I | Method, apparatus and flow cell for high sensitivity detection of fluorescent molecules |
| DE19822452C2 (de) | 1998-04-22 | 2003-02-13 | Stefan Seeger | Verfahren zur Bestimmung der Dichte lumineszierender Moleküle an einer Oberfläche, Verwendung des Verfahrens zur Bestimmung von Adsorptions- und Bindungskinetiken und Gleichgewichts- und Bindungskonstanten von Molekülen an einer Oberfläche durch Lumineszenz-Messungen und Vorrichtung zur Durchführung des Verfahrens |
| DE69835342T2 (de) | 1998-04-27 | 2007-08-23 | Corning Inc. | Verfahren zur Ablage von biologischen Proben mit Hilfe eines nachgezogenen Kapillarspeichers |
| US6689323B2 (en) | 1998-10-30 | 2004-02-10 | Agilent Technologies | Method and apparatus for liquid transfer |
| US6361671B1 (en) | 1999-01-11 | 2002-03-26 | The Regents Of The University Of California | Microfabricated capillary electrophoresis chip and method for simultaneously detecting multiple redox labels |
| JP2000208208A (ja) | 1999-01-18 | 2000-07-28 | Sony Corp | コネクタ装置及びそれを用いた電子機器並びにプラグ |
| US6249341B1 (en) | 1999-01-25 | 2001-06-19 | Amnis Corporation | Imaging and analyzing parameters of small moving objects such as cells |
| US6473176B2 (en) | 1999-01-25 | 2002-10-29 | Amnis Corporation | Imaging and analyzing parameters of small moving objects such as cells |
| US6671044B2 (en) | 1999-01-25 | 2003-12-30 | Amnis Corporation | Imaging and analyzing parameters of small moving objects such as cells in broad flat flow |
| DE19909326A1 (de) | 1999-03-03 | 2000-09-21 | Lucas Ind Plc | Vorrichtung und Verfahren zum Steuern der Fahrgeschwindigkeit eines Kraftfahrzeuges |
| US6403947B1 (en) | 1999-03-18 | 2002-06-11 | Cambridge Research & Instrumentation Inc. | High-efficiency multiple probe imaging system |
| US6242266B1 (en) | 1999-04-30 | 2001-06-05 | Agilent Technologies Inc. | Preparation of biopolymer arrays |
| AU770678B2 (en) | 1999-05-17 | 2004-02-26 | Caliper Life Sciences, Inc. | Focusing of microparticles in microfluidic systems |
| US6309886B1 (en) | 1999-06-04 | 2001-10-30 | The Regents Of The University Of California | High throughput analysis of samples in flowing liquid |
| US6811668B1 (en) | 1999-06-22 | 2004-11-02 | Caliper Life Sciences, Inc. | Apparatus for the operation of a microfluidic device |
| US6338746B1 (en) | 1999-07-23 | 2002-01-15 | Rlc Technologies, L.L.C. | Polymer-sulfur-polymer coated fertilizers |
| US6532067B1 (en) | 1999-08-09 | 2003-03-11 | The United States Of America As Represented By The Secretary Of The Army | Aerosol fluorescence spectrum analyzer for rapid measurement of single airborne particles |
| US6495104B1 (en) | 1999-08-19 | 2002-12-17 | Caliper Technologies Corp. | Indicator components for microfluidic systems |
| WO2002037096A1 (en) | 1999-10-01 | 2002-05-10 | University Of California | Microfabricated liquid sample loading system |
| US6296452B1 (en) | 2000-04-28 | 2001-10-02 | Agilent Technologies, Inc. | Microfluidic pumping |
| AU2001263286A1 (en) | 2000-05-19 | 2001-12-03 | Iowa State University Research Foundation Inc. | High-throughput methods of distinguishing at least one molecule individually in a sample comprising multiple molecules and systems for use therein |
| US6608680B2 (en) | 2000-08-25 | 2003-08-19 | Amnis Corporation | TDI imaging system for kinetic studies |
| WO2002026891A1 (en) | 2000-09-29 | 2002-04-04 | Molecular Probes, Inc. | Modified carbocyanine dyes and their conjugates |
| US6537437B1 (en) | 2000-11-13 | 2003-03-25 | Sandia Corporation | Surface-micromachined microfluidic devices |
| US6783992B2 (en) | 2001-01-03 | 2004-08-31 | Agilent Technologies, Inc. | Methods and using chemico-mechanical microvalve devices for the selective separation of components from multi-component fluid samples |
| EP1221678A1 (fr) | 2001-01-09 | 2002-07-10 | Telectronic SA | Récepteur destiné à capter un signal électromagnétique et dispositif utilisant un tel récepteur |
| US6850317B2 (en) | 2001-01-23 | 2005-02-01 | Schlumberger Technology Corporation | Apparatus and methods for determining velocity of oil in a flow stream |
| US6386219B1 (en) | 2001-02-01 | 2002-05-14 | Agilent Technologies, Inc. | Fluid handling system and method of manufacture |
| US6949377B2 (en) | 2001-03-05 | 2005-09-27 | Ho Winston Z | Chemiluminescence-based microfluidic biochip |
| US6802342B2 (en) | 2001-04-06 | 2004-10-12 | Fluidigm Corporation | Microfabricated fluidic circuit elements and applications |
| DE60233301D1 (de) | 2001-05-04 | 2009-09-24 | Biosite Inc | Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs |
| US6766817B2 (en) | 2001-07-25 | 2004-07-27 | Tubarc Technologies, Llc | Fluid conduction utilizing a reversible unsaturated siphon with tubarc porosity action |
| US20040219509A1 (en) | 2001-08-20 | 2004-11-04 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US6394305B1 (en) | 2001-08-31 | 2002-05-28 | Beverly Sydlosky | Food holder and lifter with adjustable handles |
| US6867005B2 (en) | 2001-10-24 | 2005-03-15 | Beckman Coulter, Inc. | Method and apparatus for increasing the dynamic range and accuracy of binding assays |
| US20030124592A1 (en) | 2001-10-24 | 2003-07-03 | Bioprofile, Llc | Methods for detecting genetic haplotypes by interaction with probes |
| US6599436B1 (en) | 2001-12-06 | 2003-07-29 | Sandia Corporation | Formation of interconnections to microfluidic devices |
| AU2003224953A1 (en) | 2002-04-11 | 2003-10-27 | Bristol-Myers Squibb Company | Mass spectrometer autosampler |
| MXPA03004105A (es) | 2002-05-14 | 2004-10-15 | Hoffmann La Roche | Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores. |
| AU2003298672A1 (en) | 2002-11-19 | 2005-01-28 | Singulex, Inc. | Detection of target molecules through interaction with probes |
| WO2004059293A2 (en) | 2002-12-24 | 2004-07-15 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| JP2006520463A (ja) | 2003-01-23 | 2006-09-07 | ユー．エス． ジェノミクス， インコーポレイテッド | ポリマー集団を解析するための方法 |
| FI20030652A0 (fi) | 2003-04-30 | 2003-04-30 | Susann Eriksson | Parannettu immunomääritys |
| US7074194B2 (en) | 2003-05-19 | 2006-07-11 | Ischemia Technologies, Inc. | Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin |
| US7547518B2 (en) | 2003-08-19 | 2009-06-16 | Becton, Dickinson And Company | Method of screening endothelial cells for angiogenic capability |
| EP2186913B1 (en) | 2003-11-26 | 2016-02-10 | Celera Corporation | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
| EP1725587A2 (en) | 2004-03-19 | 2006-11-29 | U.S. Genomics, Inc. | Compositions and methods for detection of single molecules |
| US7351538B2 (en) | 2004-08-23 | 2008-04-01 | U.S. Genomics | Systems and methods for detecting and analyzing polymers |
| US9040305B2 (en) | 2004-09-28 | 2015-05-26 | Singulex, Inc. | Method of analysis for determining a specific protein in blood samples using fluorescence spectrometry |
| US7572640B2 (en) | 2004-09-28 | 2009-08-11 | Singulex, Inc. | Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties |
| EP1805500A4 (en) | 2004-09-28 | 2008-05-07 | Singulex Inc | SYSTEM AND METHOD FOR THE SPECTROSCOPIC ANALYSIS OF INDIVIDUAL PARTICLES |
| US8685711B2 (en) | 2004-09-28 | 2014-04-01 | Singulex, Inc. | Methods and compositions for highly sensitive detection of molecules |
| WO2006098772A2 (en) | 2004-10-13 | 2006-09-21 | U.S. Genomics, Inc. | Systems and methods for measurement optimization |
| KR101281298B1 (ko) | 2005-09-28 | 2013-07-08 | 백톤 디킨슨 앤드 컴퍼니 | 전신성 염증 상태를 예측 또는 진단하기 위한 리소포스파티딜콜린의 검출 |
| US20070259377A1 (en) | 2005-10-11 | 2007-11-08 | Mickey Urdea | Diabetes-associated markers and methods of use thereof |
| DE602007006429D1 (de) | 2006-02-10 | 2010-06-24 | Zymogenetics Inc | Lösliches il-17rcx4 und verfahren zu dessen anwendung bei entzündungen |
| US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| EP2016394A4 (en) | 2006-04-04 | 2013-04-24 | Singulex Inc | METHOD AND COMPOSITIONS FOR HIGHLY SENSITIVE ANALYSIS OF MARKERS AND DETECTION OF MOLECULES |
| EP1887361A1 (en) | 2006-08-07 | 2008-02-13 | Bio-Rad Pasteur | Method for the prediction of vascular events |
| CN101946180B (zh) | 2007-12-19 | 2013-11-13 | 神谷来克斯公司 | 单分子检测用扫描分析器和使用方法 |
-
2011
- 2011-05-06 WO PCT/US2011/035584 patent/WO2011140484A1/en not_active Ceased
- 2011-05-06 AU AU2011249908A patent/AU2011249908A1/en not_active Abandoned
- 2011-05-06 US US13/102,683 patent/US20110301053A1/en not_active Abandoned
- 2011-05-06 CA CA 2798149 patent/CA2798149A1/en not_active Abandoned
- 2011-05-06 EP EP11778442.1A patent/EP2566971B1/en not_active Not-in-force
- 2011-05-06 JP JP2013509303A patent/JP2013525820A/ja active Pending
-
2014
- 2014-09-04 US US14/476,820 patent/US10288623B2/en not_active Expired - Fee Related
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030125231A1 (en) * | 2001-05-23 | 2003-07-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents useful in the treatment of inflammatory disease |
| JP2008500803A (ja) * | 2003-07-08 | 2008-01-17 | ジェネンテック・インコーポレーテッド | Ｉｌ−１７異種ポリペプチドとその治療上の用途 |
| JP2007506100A (ja) * | 2003-09-15 | 2007-03-15 | オクラホマ メディカル リサーチ ファウンデーション | 炎症性疾患および自己免疫疾患を診断、治療および評価するためにサイトカインアッセイを用いる方法 |
| JP2008532936A (ja) * | 2005-02-14 | 2008-08-21 | ワイス | インターロイキン−１７ｆ抗体及び他のｉｌ−１７ｆシグナル伝達拮抗物質並びにそれらの使用 |
| US20090155271A1 (en) * | 2005-09-28 | 2009-06-18 | Zymogenetics, Inc. | Il-17a and il-17f antagonists and methods of using the same |
| JP2010511056A (ja) * | 2006-11-29 | 2010-04-08 | ジェネンテック インコーポレイテッド | Ｉｌ−１７ａ／ｆヘテロ二量体ポリペプチドおよびその治療上の使用 |
| WO2008121865A1 (en) * | 2007-03-28 | 2008-10-09 | Wyeth | Methods and compositions for modulating il-17f/il-17a biological activity |
| WO2009126380A2 (en) * | 2008-03-05 | 2009-10-15 | Singulex, Inc. | Methods and compositions for highly sensitive detection of molecules |
| US20090317400A1 (en) * | 2008-05-05 | 2009-12-24 | Krzysztof Masternak | Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof |
| JP2010071833A (ja) * | 2008-09-19 | 2010-04-02 | Kyoto Univ | 関節リウマチ疾患の検査方法および検査用キット |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2566971A1 (en) | 2013-03-13 |
| WO2011140484A1 (en) | 2011-11-10 |
| CA2798149A1 (en) | 2011-11-10 |
| US20150119275A1 (en) | 2015-04-30 |
| EP2566971B1 (en) | 2019-03-27 |
| AU2011249908A1 (en) | 2012-11-22 |
| US10288623B2 (en) | 2019-05-14 |
| EP2566971A4 (en) | 2013-12-25 |
| US20110301053A1 (en) | 2011-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baillet et al. | Evaluation of serum Interleukin‐6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort | |
| Shaikh et al. | Is serum procalcitonin measurement a useful addition to a rheumatologist’s repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections | |
| zur Wiesch et al. | Pediatric rheumatology Myeloid related proteins MRP8/MRP14 may predict disease flares in juvenile idiopathic arthritis | |
| Sporek et al. | Urine NGAL is useful in the clinical evaluation of renal function in the early course of acute pancreatitis | |
| Shahriary et al. | Relationship of serum levels of interleukin 6, interleukin 8, and C-reactive protein with forced expiratory volume in first second in patients with mustard lung and chronic obstructive pulmonary diseases: systematic review and meta-analysis | |
| Wang et al. | Serum matrix metalloproteinase-2: A potential biomarker for diagnosis of epilepsy | |
| Qi et al. | The predictive and diagnostic ability of IL-6 for postoperative urosepsis in patients undergoing percutaneous nephrolithotomy | |
| Rodríguez et al. | Do serum C-reactive protein and interleukin-6 predict kidney scarring after urinary tract infection? | |
| Hassany et al. | TNF-α in the serum and synovial fluid of patients with rheumatoid arthritis: correlation with sonographic parameters: a cross-sectional study | |
| Mjaavatten et al. | Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort | |
| Klein et al. | sTREM-1 as a diagnostic biomarker for acute appendicitis in children | |
| JP2013525820A (ja) | 関節リウマチの発症に関するリスクを診断し、病期分類し、予測し、治療レスポンダーを同定するための方法 | |
| Chernoff et al. | Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores | |
| Gümüs et al. | A novel biomarker in the diagnosis of parapneumonic effusion: neutrophil gelatinase-associated lipocalin | |
| Kodama et al. | Serum levels of matrix metalloproteinase-3 and autoantibodies related to rheumatoid arthritis in the general Japanese population and their association with osteoporosis and osteoarthritis: the ROAD study | |
| Guria et al. | Clinical and radiological evaluation of osteoarthritis in knee pain patients and its association with inflammatory markers at MGM Medical College Hospital, Jamshedpur | |
| Tilinca et al. | Differences in peri-operative serum inflammatory markers between normoponderal and obese patients undergoing large joint replacement for osteoarthritis—a descriptive study | |
| Orhewere et al. | Performance of Serum Neutrophil–Gelatinase Associated Lipocalin (NGAL) in the Diagnosis of Pregnancy‑Related Acute Kidney Injury (PRAKI) in Delta, State Nigeria: A Prospective Study | |
| CN103210312A (zh) | 通过软骨酸性蛋白1 检测脑梗塞的方法 | |
| US20180003710A1 (en) | Method of assessing rheumatoid arthritis by measuring anti-ccp and anti-pik3cd | |
| Sabry et al. | Urinary orosomucoid-2 and soluble CD14 as potential biomarkers for assessment of disease activity in rheumatoid arthritis | |
| JP2010071833A (ja) | 関節リウマチ疾患の検査方法および検査用キット | |
| Almurshedi et al. | The role of interleukin-22 in the diagnosis and evaluation of disease activity in rheumatoid arthritis | |
| Allam et al. | Visfatin in Association with Severity and Activity of Primary Osteoarthritis and Rheumatoid Arthritis | |
| RU2599349C1 (ru) | Способ прогноза прогрессирования хронической обструктивной болезни легких (хобл) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140507 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140507 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140609 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141203 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150106 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150826 |